These findings provide a mechanistic link between exercise, β2-AR activation, and the manufacture of superior γδ T-cell products for adoptive cell therapy against hematologic malignancies (Supplementary Fig. S3). This evidence concerns the gene ADRB2 and hematologic disorder.